BMI1 and neoplasm: With regard to molecular subtypes, in the luminal ER+ tumours, high expression of BMI1 was significantly associated with BCSS (P = 0.04; Fig. 2b) and distant metastasis free survival (DMFS) (P = 0.04; supplementary Fig. 3).